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Stem cells are being investigated by their potential use
in regenerative medicine. There is currently a lack of
effective clinical therapy for a number conditions, such
as severe spinal cord injury (SCI). SCI can lead to
chronic paraplegia, considered an irreversible condition.
The administration of stem cells has been tested as a
potential therapy for SCI. In the present study we evalu-
ated the feasibility, safety and potential efficacy of auto-
logous mesenchymal stem cells (MSC) transplantation
in patients with chronic complete SCI.
We conducted a phase I/II, non-controlled study in 14
patients of both genders aging between 18-65 years, with
ASIA A classified chronic traumatic SCI. Baseline somato-
sensory evoked potentials (SSEP), spinal magnetic resonance
imaging (MRI) and urodynamics were assessed before and
after treatment. Pain rating was performed using the McGill
Pain Questionnaire and a visual analogue score scale.
Bone marrow-derived MSC were cultured and charac-
terized by flow cytometry, cell differentiation assays and
G-band karyotyping, showing morphological and pheno-
typic characteristics of MSC, as well as genetic stability.
MSC were injected directly into the lesion following
laminectomy and durotomy.
Transplantation of bone marrow derived MSC was an
overall safe procedure. All of the patients were discharged
within 48 hours after surgery. Only one patient developed
a post-operatory complication, evolving a liquoric fistula
that was treated by an additional surgical procedure.
Nine patients had improvements in urologic function.
All patients displayed variable improvements in sensitivity
and 8 patients developed lower limbs motor functional
gains, principally in the hip flexors. All patients had vari-
able improvements in ASIA global scores. Additionally,
6 patients had changes in the AIS score to grade B and
one to grade C. A direct correlation between motor gain
and lesion level and an inverse correlation between light
touch gain and lesion volume were found 6 months after
transplantation. One patient presented changes in SSEP 3
and 6 months after MSC transplantation.
Although there is an abundance of studies describing the
natural history of neurologic functional gains during the first
year post-SCI, there is a lack of data regarding the degree of
neurological recovery that may naturally occur during pro-
longed follow up investigation. In the present study, we
enrolled only patients with chronic and complete spinal cord
injury (ASIA A) whom had previously been subjected to
decompressive surgery and lengthy rehabilitation protocols
without acquiring significant motor or sensory gains.
Although this was not a controlled study, based on the
patient profiles and the expected spontaneous gains, our
study showed potential benefits of MSC transplantation
treatment, in variable degrees of motor and sensory improve-
ments, clinical pain measures and urodynamics parameters.
The use of MSC presents several advantages, such as
isolation from bone marrow aspirates and large-scale
expansion in cell culture procedures, which are feasible to
be performed in autologous transplantations. We conclude
that intralesional transplantation of autologous MSC in
spinal cord injury patients is safe and feasible, and may
provide some progressive benefits. We are currently begin-
ning new clinical trials based on MSC therapy for SCI.
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